Targeting inflammatory macrophages and blood vessels in atheroslerotic plaques for imaging and therapy

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Coronary heart disease due to hardening of the arteries, known as atherosclerosis, is a major health issue. The diagnosis and treatment for this disease are challenging because the atherosclerotic plaques are difficult to access in vivo. We developed reagents that can home specifically in plaques via the bloodstream. We will explore the use of these reagents to deliver imaging agents and drugs into plaques. This work will enhance diagnosis and treatment of atherosclerosis.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $453,369.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anti-inflammatory agents | atherosclerosis | blood vessels | imaging | inflammation | macrophages | mouse models | nanotechnology | targeted therapy

ACN 633 798 857